LeonaBio (LONA) Long-Term Investments (2020 - 2023)

LeonaBio (LONA) has 4 years of Long-Term Investments data on file, last reported at $10.2 million in Q2 2023.

• Quarterly Long-Term Investments fell 65.77% year-over-year to $10.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10.2 million (down 65.77% YoY) and the FY2022 annual result came in at $44.8 million, down 32.01% from the prior year.
• Long-Term Investments declined to $10.2 million in Q2 2023 per LONA's latest filing, from $33.9 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $103.6 million in Q3 2021 and bottomed at $10.2 million in Q2 2023.
• The 4-year median for Long-Term Investments is $41.9 million (2022), against an average of $50.1 million.
• The widest annual swing landed in 2021, when Long-Term Investments surged 207.97%; it then tumbled 65.77% in 2023.
• Tracing LONA's Long-Term Investments over 4 years: stood at $83.5 million in 2020, then decreased by 21.04% to $65.9 million in 2021, then plunged by 32.01% to $44.8 million in 2022, then slumped by 77.21% to $10.2 million in 2023.
• Per Business Quant, the three latest LONA Long-Term Investments figures stand at $10.2 million (Q2 2023), $33.9 million (Q1 2023), and $44.8 million (Q4 2022).

Peer Comparison